Gene · 10344
Papers3,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson's and inflammatory bowel disease. | NPJ Parkinsons Dis | 2026 | 41545356 | PubTator, text mining | PubMed |
| <p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. | Int J Oncol | 2026 | 41543185 | PubTator, text mining | PubMed |
| Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins. | Res Sq | 2026 | 41542038 | PubTator, text mining | PubMed |
| The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction. | Respir Res | 2026 | 41540423 | PubTator, text mining | PubMed |
| Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis. | J Pediatr Gastroenterol Nutr | 2026 | 41536225 | PubTator, text mining | PubMed |
| Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab. | J Allergy Clin Immunol Glob | 2026 | 41451110 | PubTator, text mining | PubMed |
| Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma. | Cell Signal | 2026 | 41314518 | PubTator, text mining | PubMed |
| Dupilumab Dampens Mucosal Type 2 Response During Acetylsalicylic Acid Challenge in N-ERD Patients. | Clin Exp Allergy | 2026 | 41309110 | PubTator, text mining | PubMed |
| Intrauterine platelet-rich plasma infusion for recurrent implantation failure: a pilot randomized controlled single-blinded clinical trial in the USA. | J Assist Reprod Genet | 2026 | 41247443 | PubTator, text mining | PubMed |
| Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles. | Allergy | 2026 | 41246813 | PubTator, text mining | PubMed |
| Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitis. | J Allergy Clin Immunol | 2026 | 41067281 | PubTator, text mining | PubMed |
| Evidence of T2/T3 Endotype Overlap in Mild-to-Severe Asthma with Chronic Rhinosinusitis: A Pilot Study. | Ann Am Thorac Soc | 2026 | 40961356 | PubTator, text mining | PubMed |
| Urgent considerations on renal immune-related adverse events in oncology practice. | Front Immunol | 2025 | 41744004 | PubTator, text mining | PubMed |
| The relationship of chemokine levels and the type of symptoms caused by NSAIDs or alcohol in patients with NSAIDs-exacerbated respiratory disease. | Front Immunol | 2025 | 41573581 | PubTator, text mining | PubMed |
| Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations. | Chin Med J Pulm Crit Care Med | 2025 | 41551016 | PubTator, text mining | PubMed |
| Aging and lung diseases: Unraveling mechanisms and therapeutic targets. | Chin Med J Pulm Crit Care Med | 2025 | 41551014 | PubTator, text mining | PubMed |
| Potential Role of Serum Cytokines and Chemokines as Biomarkers of Injury Severity and Functional Outcomes Following Pediatric Traumatic Brain Injury. | Cells | 2025 | 41511302 | PubTator, text mining | PubMed |
| Early Detection of Asthma: Exploring Inflammatory Biomarkers in Symptomatic Adults with Normal Spirometry. | J Asthma Allergy | 2025 | 41368205 | PubTator, text mining | PubMed |
| Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis. | Front Med (Lausanne) | 2025 | 41357518 | PubTator, text mining | PubMed |
| A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory Diseases. | Cells | 2025 | 41294800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10344/papers?page=5